Acrigen Biosciences
David is Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience and the Director of the Stem Cell Center at UC Berkeley. He is an experienced founder and company builder and a leader in gene therapy.
This person is not in the org chart
This person is not in any offices
Acrigen Biosciences
Acrigen Biosciences is an early-stage life science gene-editing company based in Berkeley, California. They are building a pipeline of therapies to treat genetic disorders using their proprietary precision gene-editing technology.